Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.648
-0.002 (-0.37%)
At close: Sep 6, 2024, 4:00 PM
0.641
-0.007 (-1.02%)
After-hours: Sep 6, 2024, 5:26 PM EDT
Bolt Biotherapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -66.17 | -69.2 | -88.1 | -98.59 | -60.73 | -30.49 | |
| Depreciation & Amortization | 1.84 | 1.85 | 1.67 | 1.19 | 0.61 | 1.33 | |
| Loss (Gain) From Sale of Assets | - | - | - | 0.11 | - | - | |
| Loss (Gain) From Sale of Investments | -4.35 | -4.49 | 0.18 | 2.65 | 0.03 | - | |
| Stock-Based Compensation | 9.52 | 9.22 | 9.58 | 8.5 | 1.42 | 0.51 | |
| Other Operating Activities | 3.06 | 2.95 | 3.23 | 8.56 | 13.64 | 0.04 | |
| Change in Accounts Payable | -0.61 | -3.41 | 2.77 | 6.68 | 2.88 | 2.12 | |
| Change in Unearned Revenue | -7.15 | -3.61 | -2.16 | 15.57 | -0.07 | 1.57 | |
| Change in Other Net Operating Assets | -0.05 | -2.85 | -3.66 | -1.74 | -5.1 | -1.43 | |
| Operating Cash Flow | -63.91 | -69.53 | -76.5 | -57.07 | -47.31 | -26.34 | |
| Capital Expenditures | -0.17 | -0.21 | -1.95 | -2.34 | -3.26 | -0.51 | |
| Investment in Securities | 56.84 | 71.24 | 59.82 | -229.86 | -17.33 | - | |
| Investing Cash Flow | 56.67 | 71.04 | 57.86 | -232.2 | -20.59 | -0.51 | |
| Long-Term Debt Repaid | - | - | - | - | - | -0.04 | |
| Net Debt Issued (Repaid) | - | - | - | - | - | -0.04 | |
| Issuance of Common Stock | 0.19 | 0.25 | 0.5 | 259.21 | 0.29 | 0.07 | |
| Other Financing Activities | - | - | - | - | -1.97 | - | |
| Financing Cash Flow | 0.19 | 0.25 | 0.5 | 311.11 | 39.6 | 48.63 | |
| Net Cash Flow | -7.05 | 1.77 | -18.14 | 21.84 | -28.3 | 21.78 | |
| Free Cash Flow | -64.08 | -69.73 | -78.46 | -59.4 | -50.57 | -26.85 | |
| Free Cash Flow Margin | -573.87% | -885.36% | -1369.47% | -4714.60% | -21891.77% | -12488.84% | |
| Free Cash Flow Per Share | -1.69 | -1.84 | -2.10 | -1.79 | -24.05 | -13.47 | |
| Levered Free Cash Flow | -33.36 | -39.47 | -46.18 | -41.99 | -29.22 | -15.79 | |
| Unlevered Free Cash Flow | -33.36 | -39.47 | -46.18 | -41.99 | -29.22 | -15.79 | |
| Change in Net Working Capital | -1.74 | 2.71 | -0.98 | -8.65 | -2.75 | -2.24 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.